AVXL
Anavex Life Sciences Corp. · Healthcare · Biotechnology
Señales de momentum (gestores comparables): amplitud de titulares 0.0% · flujo de acciones +2.9% · nuevas posiciones netas 0.0% · fórmula
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q3 2025
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q3 2026 | 1 | 0 | 15.28K | $23,528 | n/a | n/a |
| Q2 2026 | 80 | -1 | 31.52M | $81.72M | +7 | −8 |
| Q1 2026 | 83 | +4 | 34.46M | $105.82M | +13 | −9 |
| Q4 2025 | 79 | +2 | 31.53M | $112.26M | +2 | n/a |
| Q3 2025 | 14 | 0 | 20.35M | $181.11M | n/a | n/a |
| Q2 2025 | 11 | -2 | 18.83M | $173.63M | n/a | −2 |
| Q1 2025 | 10 | -1 | 6.83M | $58.56M | n/a | −1 |
| Q4 2024 | 11 | +3 | 6.21M | $66.68M | +3 | n/a |
| Q3 2024 | 7 | -2 | 3.52M | $20.02M | n/a | −2 |
| Q2 2024 | 9 | n/a | 3.99M | $16.85M | n/a | n/a |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (pasivo) | 7.19M | +2.7% | $63.98M | 0.0% | ▲ Add | 2 | SEC ↗ ×11 |
| 2 | The Vanguard Group ✦ (pasivo) | 5.10M | -0.1% | $45.43M | 0.0% | ▼ Trim | 2 | SEC ↗ ×5 |
| 3 | State Street Global Advisors ✦ (pasivo) | 3.29M | +11.5% | $29.26M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 4 | Geode Capital Management ✦ (pasivo) | 2.03M | +0.4% | $18.05M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 5 | Two Sigma Investments ✦ | 1.04M | +6.5% | $9.23M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 6 | Morgan Stanley ✦ | 560.15K | n/a | $4.99M | 0.0% | n/c | 1 | SEC ↗ ×5 |
| 7 | Goldman Sachs Group ✦ | 303.39K | n/a | $2.70M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 8 | Wellington Management ✦ | 288.81K | +48.2% | $2.57M | 0.0% | ▲ Add | 4 | SEC ↗ ×3 |
| 9 | Citadel Advisors ✦ | 195.72K | -39.2% | $1.74M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 10 | Marshall Wace ✦ | 182.19K | 0.0% | $1.62M | 0.0% | Held | 4 | SEC ↗ ×2 |
| 11 | JPMorgan Chase ✦ | 90.13K | n/a | $802,158 | 0.0% | n/c | 1 | SEC ↗ ×8 |
| 12 | T. Rowe Price ✦ | 45.61K | +9.2% | $406,000 | 0.0% | ▲ Add | 6 | SEC ↗ |
| 13 | AQR Capital Management ✦ | 28.04K | -3.5% | $249,517 | 0.0% | ▼ Trim | 6 | SEC ↗ ×4 |
| 14 | Fidelity (FMR) ✦ | 10.61K | +1.9% | $94,380 | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
"Their weight" = la participación de la posición en el valor de renta variable 13F reportado por ese manager: la medida de convicción. ✦ = manager curado.
Nuevos compradores
| Sin nuevos compradores rastreados este trimestre. |
Posición cerrada
| Sin salidas rastreadas este trimestre. |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 187 tenedores, 39.58M acciones, $119.37M declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué más suelen tener los titulares rastreados de este valor: recuentos de titularidad compartida, no relaciones fundamentales.